product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-TrkA (Tyr490) Antibody
catalog :
9141L
quantity :
300 ul
price :
658 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, immunoprecipitation
citations: 3
Published Application/Species/DilutionReference
  • western blot; mouse; 1:1000; fig 4
Triaca V, Sposato V, Bolasco G, Ciotti M, Pelicci P, Bruni A, et al. NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease. Aging Cell. 2016;: pubmed publisher
  • western blot; mouse; fig 2
Chen B, Ma X, Geng Z, Huang S, Zhai L, Guo Y, et al. Up-regulation of c-Jun NH2-terminal kinase-interacting protein 3 (JIP3) contributes to BDNF-enhanced neurotransmitter release. J Neurochem. 2015;135:453-65 pubmed publisher
  • western blot; human
  • immunocytochemistry; human
Takagishi T, Oda M, Kabura M, Kurosawa M, Tominaga K, Urano S, et al. Clostridium perfringens Alpha-Toxin Induces Gm1a Clustering and Trka Phosphorylation in the Host Cell Membrane. PLoS ONE. 2015;10:e0120497 pubmed publisher
product information
SKU :
9141L
Product-Name :
Phospho-TrkA (Tyr490) Antibody
Size :
300 ul
Price-(USD) :
658 USD
Species-x-Reactivity :
R, (H, M)
Applications :
Immunoprecipitation
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
140
Host :
Rabbit
Target :
TrkA (Tyr496) phosphate
Primary-Protein :
TrkA
Alt-Names :
DKFZp781I14186,High affinity nerve growth factor receptor,MTC,NTRK1,Neurotrophic tyrosine kinase receptor type 1,Oncogene TRK,TRK,TRK1,TRK1-transforming tyrosine kinase protein,TRKA,Trk-A,neurotrophic tyrosine kinase, receptor, type 1,p140-TrkA,tyrosine kinase receptor A
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.